Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm
Interventions: DRUG: Palbociclib|DRUG: Fulvestrant|DRUG: Anastrozole|DRUG: Letrozole|DRUG: Exemestane
Sponsor: Palleos Healthcare GmbH
Collaborators: WSG WOMEN´S HEALTHCARE STUDY GROUP|Cankado GmbH|Pfizer|AGO-TraFo|AGO-B|Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie e.V.